Business Context and Reporting Period
This Form 8-K Current Report was filed by Alkermes Plc. on May 24, 2017. The filing documents the results of the Company's Annual General Meeting of Shareholders held on the same date and the ratification of amendments to the 2011 Stock Option and Incentive Plan.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and shareholder voting outcomes rather than financial performance.
Material Changes and Voting Results
Shareholders approved several key proposals at the Annual Meeting:
- Director Elections: Paul J. Mitchell and Richard F. Pops were elected as Class III directors for three-year terms. Mr. Mitchell received 136,763,673 votes for, while Mr. Pops received 131,655,762 votes for.
- Executive Compensation: The advisory vote on executive compensation passed with 134,693,491 votes for and 3,112,888 votes against.
- Auditor Ratification: PricewaterhouseCoopers LLP was ratified as the independent auditor with 143,604,840 votes for.
- Stock Plan Amendment: The 2011 Stock Option and Incentive Plan was approved, increasing authorized shares by 3,000,000. The vote was 108,832,435 for and 28,974,405 against.
- Share Issuance Authority: Shareholders granted the Board authority to allot and issue shares under Irish law (115,120,611 for) and to issue shares for cash without pre-emption rights (114,385,254 for).
Guidance, Outlook, and Risks
The filing text does not provide a clear value for future guidance, management outlook, specific risks, or contingencies. The document serves as a record of completed shareholder actions.
Investor Verification Checklist
- Verify the impact of the 3,000,000 share increase in the 2011 Plan on potential dilution.
- Review the specific performance measures ratified in the amended 2011 Plan (Exhibit 10.1).
- Monitor the voting dissent rates, particularly for the Stock Plan amendment (approx. 21% against) and the pre-emption right waiver (approx. 17% against).
- Confirm the terms of the newly elected directors' three-year terms expiring in 2020.